Silver Book reference

Five-Year Clinical and Economic Outcomes Among Patients with Medically Managed Severe Aortic Stenosis: Results from a Medicare claims analysis.

10 Matching Facts

Search matching Facts:
No results to display
    • Survival rates of SAS patients ages 80+ with and without SAVR
       
    • Survival rates for SAS patients without treatment
       
    • Total medical costs per patient with medically managed SAS
       
    • Five-year health care resource use in medically managed SAS patients
       
    • Mean 5-Year Cumulative Total Medical Costs Per Medically Managed (No AVR) Severe AS Patient
       
    • SAS patient hospitalization costs
      Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
    • Survival Rates Over 5 Years for Patients with Medically Managed Severe Aortic Stenosis
       
    • Increased hospital admissions and prolonged length of stay for patients who do not undergo treatment
      Medicare severe symptomatic aortic stenosis (sSAS) patients who do not undergo treatment have an average of 1.9 hospital admissions per year and prolonged lengths of stay — 11.5 hospital days…  
    • Lifespan of Medicare patients with sSAS who do not undergo treatment
      Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.  
    • Aortic stenosis impacts majority of heart valve disease patients
      Aortic stenosis (AS) is among the most common forms of heart valve disease (HVD), affecting 2% to 3% of the adult U.S. population.